FDA issues alert on intraocular compounded moxifloxacin
- Posted on: Aug 13 2020
- Leave a response
The FDA has received case reports of toxic anterior segment syndrome (TASS) following intraocular administration of compounded drugs using moxifloxacin as a bulk drug substance.
Source: AAO
Posted in: Uncategorized
